SCHEMBL17320596

SCHEMBL17320596

COC(=O)Cc1c[nH]c2ccc(OCc3cc(CO)cc(CO)c3)cc12

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.53
PPARG P37231 1/20 0.52
PPARD Q03181 1/20 0.52
PPARA Q07869 1/20 0.52
LTA4H P09960 5/20 0.51
PLA2G2A P14555 5/20 0.51
TRPM8 Q7Z2W7 3/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
POLB P06746 1/20 0.49
HSP90AA1 P07900 1/20 0.49
HSP90AB1 P08238 1/20 0.49
HTR1D P28221 3/20 0.49
HTR1A P08908 2/20 0.49
HTR1B P28222 2/20 0.49
MTNR1A P48039 4/20 0.48
MTNR1B P49286 3/20 0.48
MAPT P10636 1/20 0.46
CYP2D6 P10635 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15747748 0.89 KDM4E (0.59) KDM4EPPARGPPARDPPARALTA4H
SCHEMBL853597 0.87 LTA4H (0.64) KDM4EPPARGPPARDPPARALTA4H
SCHEMBL30176255 0.87 LTA4H (0.64) KDM4EPPARGPPARDPPARALTA4H
SCHEMBL17320598 0.87 KDM4E (0.63) KDM4EPPARGPPARDPPARALTA4H
SCHEMBL23701834 0.86 PPARG (0.68) KDM4EPPARGPPARDPPARALTA4H
SCHEMBL23701738 0.84 PPARG (0.59) KDM4EPPARGPPARDPPARALTA4H
SCHEMBL15747662 0.83 KDM4E (0.60) KDM4ETRPM8MEN1KMT2APOLB
SCHEMBL2686551 0.81 KDM4E (0.77) KDM4ETRPM8MEN1KMT2APOLB
SCHEMBL15747724 0.81 HTR1B (0.59) KDM4EPPARGPPARDPPARAMEN1
SCHEMBL15747725 0.81 HTR1B (0.62) KDM4ELTA4HPLA2G2AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10004718-B2 Erythropoietin expression promoter TOHOKU UNIVERSITY (JP) 2018-06-26 US disclosed
US-20150353489-A1 Erythropoietin Expression Promoter KANAGAWA PREFECTURAL HOSPITAL ORGANIZATION KANAGAWA CHILDREN'S MEDICAL CENTER (JP) 2015-12-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150353489-A1 Erythropoietin Expression Promoter EPOR, NFE2L2, FOXO1 KDM4E 3503/4885PPARG 393/4885PPARD 536/4885
US-10004718-B2 Erythropoietin expression promoter EPOR, NFE2L2, FOXO1 KDM4E 3503/4885PPARG 393/4885PPARD 536/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.